Lipocine
LPCN
$4.70
Share price
1.73%
Change (1 day)
1,707.69%
Change (1 year)
Categories
Operating Margin for Lipocine (LPCN)
Operating Margin as of May 2024 (TTM): 24.50%
According to Lipocine's latest financial reports and stock price the company's current Operating Margin is 24.50%. At the end of 2021 the company had an Operating Margin of -3.93%.
Operating Margin history for Lipocine from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -3.93% | |
| 2019 | -7,883.60% | 189.42% |
| 2018 | -2,723.94% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | -30.69% | -225.27% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | -6.99% | -128.53% | 🇮🇪 Ireland |
 Agile Therapeutics
AGRX | -451.32% | -1,942.12% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.